Macular Degeneration (AMD)

Why cell therapy?

Health and Wellness begins at the cellular level and it is estimated that over 5-million patients have been treated with some form of cell therapy since the 1930s. Cell therapy is widely used in many countries within the field of regenerative medicine, as a first resort not the last.

How well does cell therapy respond to macular degeneration (AMD)?

Cell therapy is a better treatment for both wet and dry forms of macular degeneration (AMD). Cell transplantation is also a powerful tool for controlling the advanced complications of Diabetic Retinopathy (DR) and eye inflammation seen in rheumatoid arthritis of fibromyalgia patients. Statistics prove the effectiveness with no serious risk or adverse reactions. Since the 1930's over 1000 medical papers have been written on stem cell transplantation (sampling) and as the clinical experience of the past four decades has shown, Progenitor Cell treatment can slow even stop the relentless progress of macular degeneration. This implies that the transplanted cells of all organs and tissues involved - directly or indirectly - can provide the missing cells needed for rejuvenating the body's systems. After the diagnosis of macular degeneration disease is established, stem cell treatment given early can increase the success rate of the treatment.

Is cell therapy a new treatment?

Not at all... for over 70-years cell therapy has been used safely and effectively in Europe, Russia, Republic of China, New Zealand, Middle East, Pacific Rim, Central and South America, Mexico and more recently the United States, under select clinical trials.

What type of Cell therapy is Used?

ProGenaCell and its affiliated physicians offer advanced stem cell treatments for Macular Degeneration. Our physicians use a combination of two stem cell therapies that have proven effective for tissue restoration and integrated care for the incurable and obstinate diseases.

The stem cells Progenacell physicians use are pluripotent, non-specialized cells able to differentiate (turn) into other cell types. Cord blood stem cells have the highest potential for differentiation and proliferation and are not rejected by the patient's body.

Cord Blood cells have been used for over 40 years with no adverse side effects. The NIH (National Institute of Health) has stated that they have seen no cases of cancer or other health threats arising from stem-cell therapy.

ProGenaCell is one of the very few companies who also works with doctors and scientists in Germany who have perfected the use and administration of Growth Factors - with a 35-year track record.

Xenocells (Growth Factors) begin from the selection of specific organ cells from a fetal animal bred specifically for this purpose. Sheep, known to be strong and hardy animals are considered the best donor animals, with strong immunity against diseases. Moreover, sheep proteins are compatible with the human body without triggering any immune defense reactions for Macular Degeneration patients.

Our physicians have treated numerous patients with Macular Degeneration, not just improving sight, but greatly extending valuable years and improving the quality of life. Cell therapy restores function to injured, diseased, and debilitated tissues and organs.

Cord Blood cell therapy and Xeno cell therapy (Growth Factors) are administered free of any type of surgery. All of these cells are processed using the very highest standards and state-of-the-art technology available.

Treating Macular Degeneration Disease with Powerful Cellular Therapy.
  • To Hear from a ProGenaCell Representative

    Fill out an Information Request Form Today! How can we help?